Trauma Injury
1
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Arrowhead PharmaceuticalsPASADENA, CA
1 programPacked Red Blood Cell AdministrationN/A1 trial
Active Trials
Mission TherapeuticsUK - Cambridge
1 programPredictive Accuracy of PLR and PNR in Detecting ETICN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
GrifolsThrombate infusion
Mission TherapeuticsPredictive Accuracy of PLR and PNR in Detecting ETIC
Arrowhead PharmaceuticalsPacked Red Blood Cell Administration
Merit MedicalMicro Plug Set
Clinical Trials (4)
Total enrollment: 20,250 patients across 4 trials
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
Start: Sep 2023Est. completion: Mar 2027
Phase 2Enrolling By Invitation
Predictive Accuracy of PLR and PNR in Detecting ETIC
Start: Oct 2023Est. completion: Nov 2025250 patients
N/ARecruiting
Extremity Trauma At a Level 1 Trauma Center
Start: Jan 2022Est. completion: Jan 202420,000 patients
N/ACompleted
Micro Plug Set - Post Market Clinical Follow-up (PMCF) Plan
Start: Mar 2020Est. completion: Feb 2022
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 20,250 patients
4 companies competing in this space